Why the study?
Does chronic central administration of captopril reduce vascular reactivity to vasoconstrictors in spontaneously hypertensive rats?
Population
Spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats
Comparison
Captopril infused via osmotic mini pumps… vs ICV vehicle or intravenous (IV) captopril
Design
Preclinical
Follow-up
4 weeks
Authors
Loading...
Central captopril may attenuate hypertension in SHR models; hypothesis-generating for central RAS targeting, human trials required.
Does chronic central administration of captopril reduce vascular reactivity to vasoconstrictors in spontaneously hypertensive rats?
Chronic central administration of captopril attenuates the development of hypertension in spontaneously hypertensive rats by decreasing vascular reactivity to vasoconstrictors.
Berecek et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: